Clinical Trials Logo

Obstructive Sleep Apnea-hypopnea clinical trials

View clinical trials related to Obstructive Sleep Apnea-hypopnea.

Filter by:
  • None
  • Page 1

NCT ID: NCT06060756 Not yet recruiting - Endometriosis Clinical Trials

Assessment of the Occurrence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) in Women Suffering From Endometriosis

ENDOSAS
Start date: February 2024
Phase:
Study type: Observational

This observational study aims at establishing the proportion of patients suffering from endometriosis and for whom an Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) diagnosis is established. The study participation will be offered to endometriosis patients displaying symptoms that may suggest an underlying OSAHS. OSAHS diagnosis will be made according to standard of care practice and patients will be followed up to 12 months after initiating the OSAHS treatment to fill in questionnaires assessing the impact of OSAHS treatment on various endometriosis-related symptoms

NCT ID: NCT06012526 Completed - Clinical trials for Obstructive Sleep Apnea-hypopnea

The Study of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases

Start date: November 25, 2020
Phase:
Study type: Observational

This was a cross-sectional observational study to evaluate the prevalence and predictive factors of SDB in ILD and to analyze the relationship between polysomnography (PSG) findings, pulmonary function, disease severity, parenchymal involvement, and sleep questionnaires ESS and SBQ. This study included 69 patients who were diagnosed with diffuse parenchymal lung diseases by high-resolution computed tomography (HRCT) chest. All patients were subjected to clinical examination, HRCT, spirometry, full-night polysomnography, and echocardiography.

NCT ID: NCT05033626 Recruiting - Clinical trials for Obstructive Sleep Apnea

Simultaneous Operations on the Thyroid Gland and Hyoid Suspension in Patients With Combined Thyroid Pathology and OSA

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

Simultaneous operations on the thyroid gland and hyoid suspension in patients with combined thyroid pathology and moderate to severe OSA.

NCT ID: NCT04440618 Recruiting - Clinical trials for Oropharyngeal Cancer

Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

COROSAS
Start date: July 30, 2020
Phase:
Study type: Observational

The study's aim is to determinate the prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy in a locally advanced stages treated population of oropharyngeal cancer. Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies published on the subject suggest an increased risk of development of OSAHS for these patients.

NCT ID: NCT00849043 Completed - Clinical trials for Obstructive Sleep Apnea

Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea

AERO C009E
Start date: February 2009
Phase: Phase 3
Study type: Observational

The purpose of this study is to evaluate the long-term durability of the treatment and safety of the Provent device for those individuals who were enrolled in the C009 study, were diagnosed with obstructive sleep apnea-hypopnea (OSAH), and were actively using the Provent device.

NCT ID: NCT00772044 Completed - OSA Clinical Trials

Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea

AERO
Start date: November 2008
Phase: Phase 4
Study type: Interventional

Primary Endpoints: •Comparison of difference in AHI at one-week in-lab polysomnography between "device on" and "device off" nights, controlling for sleep position (supine vs. non-supine) Secondary Endpoints: By polysomnography, reduction in: - AHI with device on vs. off at 3 months, controlling for sleep position - Oxygen desaturation index with device on vs. off - Arousal index with device on vs. off - Duration of snoring with device on vs. off - Epworth Sleepiness Scale Patient acceptance, in terms of: - Refusal rate at screening - Discontinuation rate during follow-up - Daily compliance rate - Device-related adverse events - Serious adverse events

NCT ID: NCT00561860 Completed - Clinical trials for Obstructive Sleep Apnea-hypopnea

Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea

Start date: November 2007
Phase: N/A
Study type: Interventional

Although continuous positive airway pressure (CPAP) is an effective therapy for obstructive sleep apnea-hypopnea (OSAH), one of the major impediments to its use is poor compliance. Adherence with CPAP ranges from 50% to 75%, and subjective reports underestimate actual use. The primary objectives are to determine whether a remote monitoring system improves 3 month compliance (average hours of use/night), and reduces the costs of caring for patients with OSAH who are prescribed CPAP.